Comments of the Healthcare Supply Chain Association (HSCA) on USTR Request for Comments on the Proposed Modification of Action Pursuant to Section 301
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Trade Representative (USTR) on the proposed modification of action regarding Chinese exports under Section 301.
Click here for the full comments.
Related Posts
Comments of the Healthcare Supply Chain Association to FDA on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
January 11, 2019
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA CEO to Lead Panel Discussion on Innovation at AdvaMed’s MedTech Conference
September 23, 2019
Washington, DC (September 23, 2019) – The Healthcare Supply Chain...
New Analysis of U.S. Health Data Finds Healthcare Group Purchasing Organizations Save Healthcare System, Medicare and Medicaid, and Taxpayers Up to $34.1 Billion Annually
May 15, 2019
Analysis of CMS expenditure data finds that GPOs will reduce healthcare spending...
HSCA Names Leading National Healthcare Expert Khatereh Calleja as President & CEO
April 2, 2019
Washington, DC (April 2, 2019) – The Healthcare Supply Chain Association (HSCA)...